CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project aims to develop a precision diagnostic tool for predicting responses to bispecific antibody therapies in cancer treatment. By mapping cellular interactions in the immune landscape, it seeks to optimize immunotherapy effectiveness and reduce healthcare costs for patients with acute lymphoblastic leukemia.
Immunotherapies have revolutionized cancer treatment by utilizing the patient's immune system, offering hope for treating a wide range of diseases.
However, challenges such as therapy resistance, poor response rates, and high costs remain.
Precision diagnostics that accurately identify patients likely to benefit from specific immunotherapies could optimize treatment efficacy, reduce unnecessary treatments, and significantly decrease healthcare expenses. A major limitation of current predictive b…
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
